Radioactive iodine (I-131) treatment is the most effective therapy for feline hyperthyroidism, offering a cure with minimal welfare costs compared to lifelong daily medication.
From a welfare perspective, radioactive iodine offers significant advantages over lifelong daily medication for hyperthyroid cats. Daily pilling is stressful for many cats and creates chronic owner-cat conflict around medication time. Hospitalisation for radioactive iodine is stressful but time-limited — most cats tolerate the required isolation period adequately. The cure rate means that post-treatment cats experience restoration of normal thyroid function and relief from hyperthyroidism's metabolic effects — improved body condition, reduced GI symptoms, and restored quality of life — without ongoing daily treatment burden. For cats that tolerate daily medication well, methimazole remains a reasonable welfare choice, but radioactive iodine should be discussed with owners as the curative option.